The US House Select Committee on the CCP has sent letters to Pfizer, Merck, Eli Lilly, AbbVie, and Bristol Myers Squibb, requesting information on their clinical trials in China, particularly in Xinjiang and at Chinese military hospitals.
Evidence EVIDENCE
Sources 1 · Archived 0
SourceTypeReliabilityLink
美国之音中文网
2026-09-23 18:08 · 美国之音中文网 发布了新视频：美国之音中文广播 (2026年7月2日)
Media
●●●●●
Context CONTEXT
Cause
Not recorded yet
This event
US Congress Investigates Clinical Trials by Five Drug Companies in China
2026.06.29 · Verified
Effect
Not recorded yet
Coverage of this event COVERAGE